keep off Rosula Generic Name: sodium sulfacetamide and sulfur Dosage Form: aerosol, foam Overview Side Effects Dosage Professional Interactions More User Reviews Support Group Q & A Pricing & Coupons Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Rosula (Sodium Sulfacetamide 10% and Sulfar 4%) FOR EXTERNAL USE ONLY Rx Only Slideshow Acne Advice: Skin Care Solutions For Both Teens and Adults Alike DESCRIPTION Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically, sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is: Each gram of Rosula (sodium sulfacetamide 10% and sulfur 4%) Foam contains 100 mg of sodium sulfacetamide and 40 mg of sulfur in an aqueous based foam vehicle containing cetyl alcohol NF, stearyl alcohol NF, polysorbate 60, methylparaben NF, propylparaben NF, propylene glycol NF, lactic acid USR purified water USR Also contains: Propellant HFA-134A (1,1,1,2- tetrafluoroethane). CLINICAL PHARMACOLOGY Sodium sulfacetamide exhibits antibacterial activity. The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mechanism of the keratolytic activity of sulfur is unknown, but it is reported to result from the interaction of sulfur with the cysteine content of keratinocytes. Furthermore, in combination with sulfacetamide, sulfur has been reported to inhibit the growth of Propionibactehum acnes, thereby adding to the product's antibacterial activity and reducing associated inflammation. INDICATIONS Rosula Foam is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. CONTRAINDICATIONS Rosula Foam is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Rosula Foam is not to be used by patients with kidney disease. WARNINGS Although rare, severe hypersensitivity reactions to sulfonamides include Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias. Hypersensitivity reactions may occur when a sulfonamide is readministered, irrespective of the route of administration. At the first sign of hypersensitivity or skin rash, discontinue use of this preparation. Particular caution should be employed if areas of involved skin to be treated are denuded or abraded. FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of the reach of children. Contents under pressure. Do not puncture or incinerate container. Do not expose to temperatures above 120 F (49 C). PRECAUTIONS General The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the skin. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility. If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. Information for Patients Avoid contact with eyes, eyelids, lips, and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops discontinue use and consult your physician. Carcinogenesis, Mutagenesis and Impairment of Fertility Long-term studies in animals have not been performed to evaluate carcinogenic potential. Pregnancy Category C. Animal reproduction studies have not been conducted with Rosula Foam. It is also not known whether Rosula Foam can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Rosula Foam should be given to a pregnant woman only if clearly needed. Nursing Mothers It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Rosula Foam. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Rosula Foam is administered to a nursing woman. Pediatric Use Safety and effectiveness in children under the age of 12 have not been established. Adverse Reactions Although infrequent, sodium sulfacetamide may cause local irritation. DOSAGE AND ADMINISTRATION Wash affected areas before use, 1 to 2 times daily as directed by physician. Before each use, shake can vigorously, then gently tap the bottom of the can on a firm surface or in palm of other hand. Tap can 1-2 times, thenshake and tap again. Invert can so nozzle points down. (Dispensing with the can held upright will cause a loss of the propellant and can affect product delivery.) Depress the actuator and dispense a small amount of foam (not more than a dollop the size of a golf ball). Apply foam to the affected areas. Avoid contact with the eyes. WASH-OFF APPLICATION: Massage the dispensed foam into the affected areas and wait 1 to 2 minutes. Rinse thoroughly with water and pat dry. Treat the affected area 1 to 2 times daily, as directed by a physician. LEAVE-ON APPLICATION: Massage the foam into the affected areas 1 to 2 times daily, as directed by a physician. Wipe off any excess foam from actuator after use. HOW SUPPLIED Rosula Foam is supplied in a 100 g, aluminum can: NDC 10337-669-99 CAUTION: Contents under pressure. Do not puncture or incinerate container. Do not expose to heat or store at temperatures above 120 F (49 C). Store between 68 and 77 F (20 and 25 C). Protect from freezing. Store upright. Mfd. for: PharmaDerm A division of Nycomed US Inc. Melville, NY 11747 USA www.pharmaderm.com Mfd. by: Sciarra Laboratories Inc. 485-09 South Broadway Hicksville, NY 11801 IF8668 R10/09 PACKAGE LABEL PRINCIPAL DISPLAY PANEL 100 g LABEL NDC 10337-669-99 PharmaDerm Rx only Rosula (Sodium Sulfacetamide 10% and Sulfur 4%) FOAM FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. 100 g Rosula sodium sulfacetamide and sulfur aerosol, foam Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:10337-669 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sulfacetamide sodium (sulfacetamide) sulfacetamide sodium 100 mg in 1 g sulfur (sulfur) sulfur 40 mg in 1 g Inactive Ingredients Ingredient Name Strength cetyl alcohol stearyl alcohol polysorbate 60 methylparaben propylparaben propylene glycol lactic acid water Packaging # Item Code Package Description 1 NDC:10337-669-99 1 CAN (1 CAN) in 1 CARTON 1 100 g in 1 CAN Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 08/03/2010 Labeler - PharmaDerm, A division of Nycomed US Inc. (043838424) Establishment Name Address ID/FEI Operations Sciarra Laboratories Inc. 824900369 MANUFACTURE, PACK, ANALYSIS Revised: 08/2010 PharmaDerm, A division of Nycomed US Inc. Next Interactions Print this page Add to My Med List More about Rosula (sulfacetamide sodium / sulfur topical) Side Effects Dosage Information Drug Interactions Support Group Pricing & Coupons En Español 2 Reviews Add your own review/rating Drug class: topical antibiotics Consumer resources Rosula Professional resources Sodium Sulfactamide and Sulfur Wash (FDA) Other brands: Sumadan , Plexion , Sulfacleanse 8/4 , Sumaxin , ... +25 more Other Formulations Rosula Cleansing Cloth Rosula NS Related treatment guides Acne Rosacea Seborrheic Dermatitis} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Drug Class Topical antibiotics Related Drugs topical antibiotics mupirocin topical , erythromycin topical , Bactroban , neomycin topical , gentamicin topical , bacitracin topical Rosacea doxycycline , metronidazole topical , brimonidine topical , Lotemax , MetroGel , Vibramycin , ivermectin topical , Finacea , More... Seborrheic Dermatitis prednisone , hydrocortisone topical , ketoconazole topical , dexamethasone , Decadron , Deltasone , ciclopirox topical , More... Acne doxycycline , clindamycin topical , erythromycin topical , minocycline , tretinoin topical , tetracycline topical , dapsone topical , More... Rosula Rating 2 User Reviews 9.5 /10 2 User Reviews 9.5 Rate it!} } optimum
of wonderful Rosula twine
EmoticonEmoticon